Skip to main content
FDA Updates
Zynlonta First FDA-Approved CD19-Directed Therapy for Large B-Cell Lymphoma
Read More
FDA Updates
Jemperli First FDA-Approved Immunotherapy for Advanced Endometrial Cancer with dMMR Biomarker
Read More
FDA Updates
Keytruda Received FDA Approval for First-Line Treatment of HER2-Positive Advanced Gastric Cancer
Read More
FDA Updates
Opdivo First FDA-Approved Immunotherapy for First-Line Treatment of Advanced Gastric Cancer
Read More
FDA Updates
Trodelvy Receives New Indication for Advanced Urothelial Cancer
Read More
FDA Updates
Sarclisa Receives New Indication for Relapsed or Refractory Multiple Myeloma
Read More
IWTI Best Practices in GU Navigation
Interview with the Innovators
The Multidisciplinary Care Approach to Cancer Care Management
Megan Price, MSN, APRN, FNP-C, Virginia Seery, MSN, RN, ANP-BC, AOCNP, Laura Wood, RN, MSN, OCN
Read More
IWTI Best Practices in GU Navigation
Interview with the Innovators
The Clinical Advantages of Combination Therapies in Advanced RCC
Megan Price, MSN, APRN, FNP-C, Virginia Seery, MSN, RN, ANP-BC, AOCNP, Laura Wood, RN, MSN, OCN
Read More
IWTI Best Practices in GU Navigation
Interview with the Innovators
Improving the Patient Experience by Helping Patients Navigate Their Cancer Care
Megan Price, MSN, APRN, FNP-C, Virginia Seery, MSN, RN, ANP-BC, AOCNP, Laura Wood, RN, MSN, OCN
Read More
Original Research, Dose Escalation/Reduction, Adverse Events, Methotrexate
Assessment of High-Dose Methotrexate Management Guideline in Adults with Cancer at an Academic Medical Center
Andrew Kowalski, PharmD, BCOP, Sara Mohamed Jaszczur, PharmD, BCOP, Michelle Nadeau-Nguyen, PharmD, BCPS, Man-Yee Merl, PharmD, BCOP
Andrew Kowalski, PharmD, BCOP; Sara Mohamed Jaszczur, PharmD, BCOP; Michelle Nadeau-Nguyen, PharmD, BCPS; Man Yee Merl, PharmD, BCOP
Read More
Page 91 of 199
Results 901 - 910 of 1986